Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04766164
Other study ID # MCC-20853
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 17, 2021
Est. completion date July 6, 2022

Study information

Verified date November 2022
Source H. Lee Moffitt Cancer Center and Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study will provide important insight into current HPV vaccine knowledge/awareness, health beliefs, affect, vaccine discussions, decision preparedness, and vaccine intentions and behaviors among those ages 18-45, while examining potential differences in responses between those ages 18-26 and those ages 27-45 and vaccinated and unvaccinated individuals.


Description:

The study will provide important insight into current HPV vaccine knowledge/awareness, health beliefs, affect, vaccine discussions, decision preparedness, and vaccine intentions and behaviors among those ages 18-45, while examining potential differences in responses between those ages 18-26 and those ages 27-45 and vaccinated and unvaccinated individuals. In addition, the study will illuminate gaps in knowledge and awareness as well as the education intervention preferences (e.g., intervention platform, source of information, timing of intervention) of individuals ages 18-45. Among those ages 27-45, shared clinical decision-making is recommended. Compared to individuals ages 18-26, individuals ages 27-45 may need to be supported uniquely so that they are prepared to engage in shared clinical decision-making about HPV vaccination with their healthcare provider. Thus, among unvaccinated individuals ages 27-45, for whom shared clinical decision-making is recommended, preparedness for engagement in shared clinical decision-making will be assessed and explored. The study also will allow investigators to identify how best to target information to young adults and mid-adults both for themselves, and among those with children, for their children.


Recruitment information / eligibility

Status Completed
Enrollment 4000
Est. completion date July 6, 2022
Est. primary completion date July 6, 2022
Accepts healthy volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Age 18-45 - Living in the United States - a KnowledgePanel panelist directly or via verified partners - Have internet access - Able to read, write and understand English - Individuals can participant regardless of their HPV vaccination status Exclusion Criteria: - Individuals who do not meet inclusion criteria

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Survey
Data will be obtained via self-report from participants via a one-time Qualtrics survey.

Locations

Country Name City State
United States Moffitt Cancer Center Tampa Florida

Sponsors (1)

Lead Sponsor Collaborator
H. Lee Moffitt Cancer Center and Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary HPV Vaccine Knowledge Data from survey will describe HPV and HPV vaccine knowledge, health beliefs, attitudes, affect, health literacy, health care experiences, vaccine discussions and information sources, preparedness for shared decision-making and HPV vaccine uptake and intentions and examine relationships between these variables among a national sample of U.S. adults (N=4,000) ages 18-45 years. Day 1
Primary HPV-Related Educational Intervention Preferences Data from survey will describe intervention preferences and associations between intervention preferences and sociodemographic variables (e.g., age, gender, race, ethnicity, socioeconomic status, employment status, parental status, and insurance status). Day 1